Chances and Limits of Cord Blood Transplantation
Cord blood (CB) as a new source of grafting material has evoked great expectations. Because it is derived from the fetus, it contains immature cells with unusual properties: they possess higher proliferation capacity for regenerating the hematopoietic system after ablative treatment than does grafting material gained from adults, and they retain differentiation capacities for some non-hematopoietic tissues as well. The main application today is straightforward use as sibling or unrelated allograft during myoablative treatment of malignant disease. Important indications are also given in children with inherited blood cell diseases, hemoglobinopathies, immune deficiencies and other genetic diseases such as osteopetrosis and storage diseases; beside this, new perspectives for tissue replacement in the case of organ damage in adults open up, and both applications foster a family-centered strategy for CB storage.
KeywordsToxicity Europe DMSO Leukemia Transportation
Unable to display preview. Download preview PDF.
- Douay, McNiece (2000) Contributions at the international conference on haematopoietic stem cell biology and transplantation, Paris, 25–29 March 2000Google Scholar
- Hénon Ph, Sovalat H, Becker M, Arkam Y, Ojeda-Oribe M, Raidot JP, Husseini F, Wunder E, Bouderont D, Audhuy B (1998) Primordial role of CD34+38-cells in early and late trilineage haemopoietic engraftment after autologous blood cell transplantation. Br J Haematol 103: 568–581PubMedCrossRefGoogle Scholar
- Kögler G, Somville T, Gobel U, Hackenberg P, Knipper A, Fischer J, Adams O, Krempe C, McKenzi C, Ruttgers H, Meier W, Bellmann O, Streng H, Ring A, Rosseck U, Rocha V, Wernet P (1999) Haematopoietic transplant potential of unrelated and related cord blood: the first six years of the Eurocord/Netcord Bank Germany. Klin Padiatr 211(4): 224–232PubMedCrossRefGoogle Scholar
- Lampeter EF, Egger D (2000) Storage of cord blood for related or unrelated use. In: Schultze W (ed) High-dose therapy and transplantation of hematopoietic cells. Blackwell Wissenschafts-Verlag, BerlinGoogle Scholar
- To LB (1994) Establishment of a clinical threshold cell dose: correlation between CFU-GM and duration of aplasia. In: Wunder E, Sovalat H, Henon PR, Serke S (eds) Hematopoietic stem cells. Mulhouse Manual Alpha Med Press, Dayton OHGoogle Scholar
- Wagner JE, Rosenthal J, Sweetman R et al (1996) Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 795-802Google Scholar